Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for Bowel Perfusion in Necrotizing Enterocolitis
NCT03549507Phase 3Terminated
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Nov 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfur hexafluoride in necrotizing enterocolitis (NEC), sponsored by Children's Hospital of Philadelphia. Started Nov 2020; status: terminated.
02
Drugs
sulfur hexafluoride
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT03549507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549507.